Hu Kaijun
$4.9B
Born
Jan 01, 1962
Age
63
Source of Wealth
Pharmaceuticals
Residence
Beijing, Beijing
Citizenship
China
Marital Status
Children
0
Education
- Hu Kaijun is chairman and CEO of China Grand Enterprises, an investment company with interests in healthcare, real estate, agriculture and financial services.
- China Grand is the parent of three publicly-traded companies: Grand Pharmaceutical, Huadong Medicine (a wholesaler) and Grand Industrial Holding (a trading business).
- Grand Pharmaceutical agreed to buy 87.5% of U.S.-based vascular drug maker BlackSwan Vascular for $37.5 million in 2023.
- Hu also wholly owns Beijing Yuanda Huachuang Investment, where he also serves as chairman and CEO.
- Hu's wealth is derived primarily from Grand China's stakes in Huadong Medicine and Grand Pharmaceutical.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|